Developing and streamlining clinical trial services to support pediatric drug development across 21 countries in

Sabah Attar1,2, Francisca P Figueiras3,4, Carla Peacock1

  • 1Department of Women's and Children's Health, Liverpool Women's NHS Foundation Trust, University of Liverpool, Liverpool, United Kingdom.

Frontiers in Medicine
|June 27, 2025
PubMed

Insights

The conect4children network developed high-quality pediatric clinical trial support services across 21 countries. This initiative improved multinational pediatric trial coordination and established a sustainable non-profit organization for future infrastructure.

Area of Science:

  • Clinical pharmacology and pediatric research.
  • Public-private partnerships in healthcare innovation.

Background:

  • Multinational clinical trials, especially in pediatrics, require efficient, high-quality, and scalable support services.
  • Gaps in communication, site identification, feasibility, and trial support hinder pediatric trial success.

Purpose of the Study:

  • To explore the development and implementation of high-quality trial support services within the conect4children (c4c) network.
  • To measure the progression and operational maturity of these services using Technology Readiness Levels (TRLs) and Service Readiness Levels (SRLs).

Main Methods:

  • A public-private partnership (Innovative Medicines Initiative 2) involving pharmaceutical companies, academic, and third-sector organizations.
  • Development and deployment of standardized trial support services across 220+ sites in 21 countries.
  • Utilizing TRLs and SRLs frameworks to assess service development and operational maturity.

Main Results:

  • The c4c network successfully developed and implemented high-quality trial support services, moving from SRL1 to SRL8 over six years.
  • Streamlined targeted aspects of trial support, enhancing multinational pediatric trial coordination.
  • Established a sustainable non-profit organization (conect4children Stichting) for long-term infrastructure.

Conclusions:

  • The c4c initiative provides a scalable model for improving pediatric clinical trial support services globally.
  • Lessons learned regarding site readiness variability and data collection methodologies offer generalizable insights for research networks.
  • The establishment of a sustainable non-profit organization ensures the long-term viability of the developed infrastructure beyond initial funding.

Related Concept Videos

Clinical Trials: Overview01:11

Clinical Trials: Overview

Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
3.4K
Preclinical Development: Overview01:28

Preclinical Development: Overview

Preclinical development consists of a series of tests that ensure the safety and efficacy of a new therapeutic compound before it is tested in humans. There are four main phases to this process. First, safety pharmacology tests are conducted to ensure the drug does not produce any acutely harmful effects. These tests examine parameters such as bronchoconstriction, cardiac dysrhythmias, blood pressure changes, and ataxia. Next, preliminary toxicological testing is performed to determine the...
4.9K
Clinical Trials01:16

Clinical Trials

Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
8.7K
Drug Discovery: Overview01:26

Drug Discovery: Overview

Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
8.8K
Drug Administration and Therapy Phases: Overview01:26

Drug Administration and Therapy Phases: Overview

Drugs, the chemical agents used in diagnosing, treating, or preventing diseases, undergo a four-phase process of development: pharmaceutic, pharmacokinetics, pharmacodynamics, and therapeutic.
The pharmaceutical phase focuses on leveraging the physicochemical properties of the drug to design and manufacture an effective product. Variants include orally administered tablets or capsules, topical creams or ointments, and parenteral-delivery solutions or emulsions.
The pharmacokinetic phase...
770
Prescription, Nonprescription and Orphan Drugs01:02

Prescription, Nonprescription and Orphan Drugs

Prescription drugs require a prescription from a medical practitioner and can only be obtained from a pharmacy. They have many applications, including treating pain, anxiety, and hypertension.
The misuse and addiction to prescription drugs is a growing problem that can affect people of all age groups, specifically teenagers. This can happen when prescription medications are used in ways not intended by the prescriber, such as taking someone else's prescription or using medication for...
857